NCT01497912View on ClinicalTrials.gov

Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2010

Conditions
Type 1 Diabetes MellitusDyslipidemia
Interventions
DRUG

Atorvastatin

Atorvastatin 80mg once daily for 8 weeks

DRUG

Placebo

Placebo tablet once daily for 8 weeks

Trial Locations (1)

182 88

Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT01497912 - Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes | Biotech Hunter | Biotech Hunter